Inozyme Pharma GAAP EPS of -$0.38 beats by $0.02
Inozyme Pharma press release (NASDAQ:INZY): Q1 GAAP EPS of -$0.38 beats by $0.02. Cash, cash equivalents, and short-term investments were ...
Inozyme Pharma press release (NASDAQ:INZY): Q1 GAAP EPS of -$0.38 beats by $0.02. Cash, cash equivalents, and short-term investments were ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.